Patents by Inventor Manuel Raga

Manuel Raga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical topical compositions
    Patent number: 10022363
    Abstract: The invention provides pharmaceutical stable semisolid topical compositions comprising between 0.2 to 5% of a des-fluoroquinolone compound, and a suitable carrier to manufacture an ointment or a cream.
    Type: Grant
    Filed: May 4, 2016
    Date of Patent: July 17, 2018
    Assignee: FERRER INTERNACIONAL, S.A.
    Inventors: Cristina Tarragó, Benjamin Santos, Manuel Raga, Antonio Guglietta
  • PHARMACEUTICAL TOPICAL COMPOSITIONS
    Publication number: 20160243104
    Abstract: The invention provides pharmaceutical stable semisolid topical compositions comprising between 0.2 to 5% of a des-fluoroquinolone compound, and a suitable carrier to manufacture an ointment or a cream.
    Type: Application
    Filed: May 4, 2016
    Publication date: August 25, 2016
    Applicant: Ferrer Internacional, S.A.
    Inventors: Cristina TARRAGÓ, Benjamin SANTOS, Manuel RAGA, Antonio GUGLIETTA
  • Pharmaceutical topical compositions
    Patent number: 9399014
    Abstract: The invention provides pharmaceutical stable semisolid topical compositions comprising between 0.2 to 5% of a des-fluoroquinolone compound, and a suitable carrier to manufacture an ointment or a cream.
    Type: Grant
    Filed: March 5, 2014
    Date of Patent: July 26, 2016
    Assignee: FERRER INTERNACIONAL, S.A.
    Inventors: Cristina Tarrago, Benjamin Santos, Manuel Raga, Antonio Guglietta
  • Pharmaceutical Topical Compositions
    Publication number: 20160030338
    Abstract: The invention provides pharmaceutical stable semisolid topical compositions comprising between 0.2 to 5% of a des-fluoroquinolone compound, and a suitable carrier to manufacture an ointment or a cream.
    Type: Application
    Filed: October 14, 2015
    Publication date: February 4, 2016
    Inventors: Christina TARRAGO, Benjamin SANTOS, Manuel RAGA, Antonio GUGLIETTA
  • Pharmaceutical topical compositions
    Patent number: 9180200
    Abstract: The invention provides pharmaceutical stable semisolid topical compositions comprising between 0.2 to 5% of a des-fluoroquinolone compound, and a suitable carrier to manufacture an ointment or a cream.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: November 10, 2015
    Assignee: FERRER INTERNATIONAL, S.A.
    Inventors: Cristina Tarragó, Benjamin Santos, Manuel Raga, Antonio Guglietta
  • Pharmaceutical Topical Compositions
    Publication number: 20140187578
    Abstract: The invention provides pharmaceutical stable semisolid topical compositions comprising between 0.2 to 5% of a des-fluoroquinolone compound, and a suitable carrier to manufacture an ointment or a cream.
    Type: Application
    Filed: March 5, 2014
    Publication date: July 3, 2014
    Applicant: Ferrer Internacional, S.A.
    Inventors: Cristina TARRAGO, Benjamin SANTOS, Manuel RAGA, Antonio Guglietta
  • Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine
    Patent number: 8354430
    Abstract: A method is provided for the treatment of sleep apnea and other conditions wherein an effective amount of crystalline 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine monohydrochloride of formula (I): optionally comprising water up to 6%, and having an X-ray diffractogram that comprises characteristic peaks (2?) at 11.2°, 19.9°, 20.7° and 34.1°±0.2° is administered to a patient in need thereof.
    Type: Grant
    Filed: June 7, 2012
    Date of Patent: January 15, 2013
    Assignee: Bioprojet
    Inventors: Manuel Raga, Juan Sallares, Marta Guerrero, Antonio Guglietta, Jean-Michel Arrang, Jean-Charles Schwartz, Holger Stark, Walter Schunack, Xavier Ligneau, Jeanne-Marie Lecomte, Charon Ganellin
  • MONOHYDROCHLORIDE SALT OF 1-[3-[3-(4-CHLOROPHENYL) PROPOXY]PROPYL]-PIPERIDINE
    Publication number: 20120289546
    Abstract: A method is provided for the treatment of sleep apnea and other conditions wherein an effective amount of crystalline 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine monohydrochloride of formula (I): optionally comprising water up to 6%, and having an X-ray diffractogram that comprises characteristic peaks (2?) at 11.2°, 19.9°, 20.7° and 34.1°±0.2° is administered to a patient in need thereof.
    Type: Application
    Filed: June 7, 2012
    Publication date: November 15, 2012
    Inventors: Manuel RAGA, Juan Sallares, Marta Guerrero, Antonio Guglietta, Jean-Michel Arrang, Jean-Charles Schwartz, Holger Stark, Walter Schunack, Xavier Ligneau, Jeanne-Marie Lecomte, Charon Ganellin
  • Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy] propyl] -piperidine
    Patent number: 8207197
    Abstract: The invention relates to new crystalline 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine monohydrochloride, the respective manufacture and methods of use, and compositions containing such a compound.
    Type: Grant
    Filed: February 6, 2006
    Date of Patent: June 26, 2012
    Assignee: Bioprojet
    Inventors: Manuel Raga, Juan Sallares, Marta Guerrero, Antonio Guglietta, Jean-Michel Arrang, Jean-Charles Schwartz, Holger Stark, Walter Schunack, Xavier Ligneau, Jeanne-Marie Lecomte, Charon Ganellin
  • PHARMACEUTICAL TOPICAL COMPOSITIONS
    Publication number: 20110263646
    Abstract: The invention provides pharmaceutical stable semisolid topical compositions comprising between 0.2 to 5% of a des-fluoroquinolone compound, and a suitable carrier to manufacture an ointment or a cream.
    Type: Application
    Filed: October 16, 2009
    Publication date: October 27, 2011
    Applicant: FERRER INTERNACIONAL, S.A.
    Inventors: Cristina Tarragó, Benjamin Santos, Manuel Raga, Antonio Guglietta
  • CAPSULE FOR THE PREVENTION OF CARDIOVASCULAR DISEASES
    Publication number: 20110086094
    Abstract: The invention relates to a capsule for the prevention of cardiovascular diseases which comprises coated tablets of acetylsalicylic acid, coated tablets of simvastatin or pravastatin, and coated tablets of lisinopril, ramiphl or perindopril. The capsules are used for the prevention of cardiovascular diseases in high-risk populations.
    Type: Application
    Filed: March 25, 2009
    Publication date: April 14, 2011
    Applicants: Ferrer Internacional S.A., Fundacion Centro Nacional de Investigaciones Cardi ovasculares Carlos III
    Inventors: Marta Guerrero, Anna Orriols, Pablo Martín, Manuel Raga
  • Monohydrochloride Salt of 1-[3-[3-(4-Chlorophenyl) Propoxy] Propyl] -Piperidine
    Publication number: 20080221162
    Abstract: The invention relates to new crystalline 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine monohydrochloride, the respective manufacture and methods of use, and compositions containing such a compound.
    Type: Application
    Filed: February 6, 2006
    Publication date: September 11, 2008
    Inventors: Manuel Raga, Juan Sallares, Marta Guerrero, Antonio Guglietta, Jean-Michel Arrang, Jean-Charles Schwartz, Holger Stark, Walter Schunack, Xavier Ligneau, Jeanne-Marie Lecomte, Charon Ganellin
  • Pharmaceutical compositions of sertaconazole for vaginal use
    Publication number: 20060165803
    Abstract: The invention relates to monodose mucoadhesive vaginal compositions of sertaconazole or a pharmaceutically acceptable salt thereof for the treatment of vulvovaginal candidiasis.
    Type: Application
    Filed: December 17, 2003
    Publication date: July 27, 2006
    Inventors: Celia Palacin, Marta Guerrero, Manuel Raga, Alfonso Romero, Antonio Gulietta
  • Use of CDP-choline for the prophylactic treatment of cerebral ischemia
    Publication number: 20050222077
    Abstract: The invention describes a prophylactic treatment of cerebral ischemia with CDP-Choline in patients who have undergone major surgery or are at risk of suffering an acute ischemic event.
    Type: Application
    Filed: May 20, 2005
    Publication date: October 6, 2005
    Inventors: Rafael Foguet, Jorge Ramentol, Isidro Ferrer, Rafael Lozano, Julio Secades, Manuel Raga, Josep Castello, Jose Ortiz
  • Polymorph B of 1-(diphenylmethyl)-4-?3-(2-phenyl-1,3-dioxolan-2-YL) propyl! piperazine
    Patent number: 5852021
    Abstract: Polymorph B of (1-diphenylmethyl)-4-?3-(2-phenyl-1,3-dioxolan-2-yl)propyl!piperazine have been identified. A process for its preparation and its use are described.
    Type: Grant
    Filed: December 27, 1996
    Date of Patent: December 22, 1998
    Assignee: Ferrer Internacional, S.A.
    Inventors: Rafael Foguet Ambros, Lluis Anglada Burniol, Manuel Raga Carreno, Jose A. Ortiz Hernandez, Aurelio Sacristan Munoz, Josep M. Castello Barenys
  • 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
    Patent number: 5135943
    Abstract: The 1H-imidazole derivative compound of formula I: ##STR1## and its nontoxic addition salts, particularly the nitrate addition salt, are more effective as antimycotic agents and are unexpectedly safer than the corresponding prior art compounds, especially the compound in which the sulfur atom of the benzothiophene ring of the above compound is replaced by an oxygen atom. Pharmaceutical compositions containing an effective amount of the compound of formula I, e.g. 1 to 5% by weight, in a pharmaceutical carrier are safer, more effective, and, in some cases, more reliable with fewer side effects than currently used antimycotic preparations.
    Type: Grant
    Filed: February 1, 1991
    Date of Patent: August 4, 1992
    Assignee: Ferrer Internacional S.A.
    Inventors: Rafael Foguet, Marcial Moreno, Manuel Raga, Rosa M. Cuberes, Jose M. Castello, Jose A. Ortiz
  • Piperazine derivative and pharmaceutical composition containing the same
    Patent number: 4603134
    Abstract: A piperazine derivative is disclosed of formula (I): ##STR1## and the non-toxic addition salts thereof, along with a process for preparation, pharmaceutical composition, and method of treating conditions characterized by histamine activity.
    Type: Grant
    Filed: January 11, 1985
    Date of Patent: July 29, 1986
    Assignee: Ferrer International, S.A.
    Inventors: Rafael Foguet, Santiago Gubert, Manuel Raga, Aurelio Sacristan, Jose A. Ortiz